1-(4-(4-(2-Aminopyridin-4-yl)butoxy)-3-methoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea

ID: ALA4097599

Cas Number: 2092921-50-9

PubChem CID: 92045043

Max Phase: Preclinical

Molecular Formula: C24H32N6O2S

Molecular Weight: 468.63

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(NC(=S)NCCCn2cncc2C)ccc1OCCCCc1ccnc(N)c1

Standard InChI:  InChI=1S/C24H32N6O2S/c1-18-16-26-17-30(18)12-5-10-28-24(33)29-20-7-8-21(22(15-20)31-2)32-13-4-3-6-19-9-11-27-23(25)14-19/h7-9,11,14-17H,3-6,10,12-13H2,1-2H3,(H2,25,27)(H2,28,29,33)

Standard InChI Key:  MXAZSKBTKUGBLI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
    0.0982   -4.0849    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6530   -3.7531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1990   -4.3645    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7904   -5.0764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0134   -4.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6311   -5.4449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8053   -3.6751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5136   -4.0826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2207   -3.6729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9291   -4.0803    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6361   -3.6706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3445   -4.0781    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6348   -2.8534    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.0515   -3.6684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7572   -4.0791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4638   -3.6700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4629   -2.8520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7496   -2.4447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0460   -2.8561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1695   -2.4413    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1671   -1.6241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8736   -1.2134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8712   -0.3963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1720   -4.0778    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1729   -4.8950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5777    0.0186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5753    0.8358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2817    1.2443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2797    2.0623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5703    2.4721    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8614    2.0535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8670    1.2342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1511    2.4584    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  1  5  1  0
  5  6  1  0
  1  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 16 24  1  0
 24 25  1  0
 23 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 31 33  1  0
M  END

Alternative Forms

Associated Targets(Human)

QPCT Tchem Glutaminyl-peptide cyclotransferase (1121 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
QPCTL Tchem Glutaminyl-peptide cyclotransferase-like protein (114 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Qpct Glutaminyl-peptide cyclotransferase (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-22 (3261 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (8163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.63Molecular Weight (Monoisotopic): 468.2307AlogP: 3.96#Rotatable Bonds: 12
Polar Surface Area: 99.25Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 13.48CX Basic pKa: 7.72CX LogP: 3.29CX LogD: 2.78
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.27Np Likeness Score: -1.02

References

1. Hoang VH, Tran PT, Cui M, Ngo VT, Ann J, Park J, Lee J, Choi K, Cho H, Kim H, Ha HJ, Hong HS, Choi S, Kim YH, Lee J..  (2017)  Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design.,  60  (6): [PMID:28234463] [10.1021/acs.jmedchem.7b00098]
2. Hoang VH, Ngo VTH, Cui M, Manh NV, Tran PT, Ann J, Ha HJ, Kim H, Choi K, Kim YH, Chang H, Macalino SJY, Lee J, Choi S, Lee J..  (2019)  Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design.,  62  (17): [PMID:31411468] [10.1021/acs.jmedchem.9b00751]
3. Van Manh N, Hoang VH, Ngo VTH, Ann J, Jang TH, Ha JH, Song JY, Ha HJ, Kim H, Kim YH, Lee J, Lee J..  (2021)  Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design.,  226  [PMID:34536669] [10.1016/j.ejmech.2021.113819]

Source